PFE - Arvinas stock rises on fast track status for breast cancer candidate with Pfizer
2024-02-06 07:03:50 ET
More on Arvinas, Pfizer, etc.
- Pfizer: Simply Too Cheap To Ignore
- Pfizer Is Down 54% From Highs, Now Yields 6.1%
- Pfizer: Reviewing Q4 Earnings, FY24 Guidance - Why I Disagree With The Market
- Pharma giants turn to China in search of targeted cancer drugs
- Pfizer-Genmab cervical cancer drug gets accepted for EU review